| COMPOSITION: | Empagliflozin 25 mg & Linagliptin 5 mg (Blister) |
| FORMULATION: | TABLET |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | EMPIFORD-25 L is an anti-diabetic medication, used to treat type 2 diabetes in adults. It is a combination of two active substances- empagliflozin and linagliptin. These medicines work together to lower the raised blood sugar levels by improving insulin release. The excess sugar is excreated via urine. |
| SIDE EFFECTS: | Cough, rash, itching, frequent urination, low blood sugar levels |
| DOSAGE/DIRECTIONS FOR USE: | As prescribed by the Physician. |
